Leads and Pharmaceutical - Pharma Rep Focus

Fat-shedding pill’s data lead to a $132M funding round for startup Rivus Pharma

MedCity News

SEPTEMBER 23, 2022

Rivus Pharmaceuticals’ Series B round will finance ongoing clinical development of its lead drug, a pill that targets mitochondria to increase caloric expenditure.

Leads

Leads Pharma Pharmaceutical Biopharma

Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study

MedCity News

SEPTEMBER 9, 2024

The weight loss results for the Terns Pharmaceuticals drug TERN-601 come from a four-week Phase 1 clinical trial. The post Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study appeared first on MedCity News.

Leads

Leads Pharma Pharmaceutical Medical

Theseus Pharma Lays Off Staff, Explores Options Months After Toxicity Scuttles Lead Drug

MedCity News

NOVEMBER 14, 2023

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.”

Leads

Leads Pharma Pharmaceutical Patients

After prior trial flop, EyePoint's Duravyu bounces back with promising data in DME

Fierce Pharma

OCTOBER 28, 2024

Earlier this year, EyePoint Pharmaceuticals’ drug-device combo Duravyu missed the mark in a non-proliferative diabetic retinopathy (NPDR) study, raising doubts about the product’s potential in seve | EyePoint released new diabetic macular edema data Monday that a Mizuho Securities analyst described as "very promising."

Leads

Leads Pharmaceutical

FDA Reconsideration Leads to Approval of Takeda Drug for Rare Esophagus Disorder

MedCity News

FEBRUARY 12, 2024

FDA approval of Takeda Pharmaceutical drug Eohilia introduces a new therapeutic option for patients with eosinophilic esophagitis, inflammation of the esophagus that causes swallowing difficulty. It will compete against Dupixent, a Sanofi and Regeneron Pharmaceuticals drug already approved for this disorder.

FDA

FDA Leads Pharmaceutical Patients

In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts

Fierce Pharma

MAY 9, 2024

While Vertex leads in patient starts, bluebird has activated more treatment centers. It’s not an easy question to answer.

Leads

Leads Patients FDA Pharmaceutical

New Hemophilia Data Lead FDA to Delay Decision for BioMarin Gene Therapy

MedCity News

MARCH 7, 2023

BioMarin Pharmaceutical’s submission of additional data for patients treated with its hemophilia A gene therapy, Roctavian, mean that the FDA will push out a regulatory decision to early summer. But it could be worth the wait as analysts anticipate FDA approval and project Roctavian becoming one of BioMarin’s biggest products.

FDA

FDA Leads Pharmaceutical Patients

Pfizer moves to settle more than 10,000 Zantac cases in state courts: Bloomberg

Fierce Pharma

MAY 8, 2024

Following the lead of French pharmaceutical giant Sanofi, Pfizer has agreed to settle more than 10,000 personal-injury claims from users of heartburn drug Zantac, resolving litigation in several U. state courts, according to Bloomberg.

Leads

Leads Pharmaceutical

‘Challenging Market’ Leads MorphoSys to Cut Preclinical R&D, Turn Focus to Cancer

MedCity News

MARCH 2, 2023

MorphoSys’s emphasis on its clinical-stage cancer programs puts the spotlight on a myelofibrosis drug candidate from its 2021 acquisition of Constellation Pharmaceuticals. That small molecule could compete against drug candidates from GSK and Merck.

Leads

Leads Marketing Pharmaceutical Biopharma

Amylyx ALS drug’s winding regulatory path leads to long-awaited FDA approval

MedCity News

SEPTEMBER 30, 2022

An Amylyx Pharmaceuticals drug developed to slow the progression of amyotrophic lateral sclerosis is now approved, making it just the third FDA-approved treatment for the disease. Amylyx will market its new product under the name “Relyvrio.”.

FDA

FDA Leads Pharmaceutical Marketing

RA Capital Leads $150M Financing for Septerna and Lead Drug With Oral Edge in Rare Hormone Disease

MedCity News

JULY 11, 2023

Septerna Therapeutics’ Series B financing will support plans to reach the clinic with a pill for a rare disease whose only approved therapy is a Takeda Pharmaceutical drug that’s leaving the market. Potential rival therapies are all injectables.

Leads

Leads Pharmaceutical Marketing Biopharma

Novo Nordisk Follows Eli Lilly’s Lead, Lowering Insulin Prices up to 75%

MedCity News

MARCH 14, 2023

Flattening revenue for the pharmaceutical giant’s insulin products is offset by demand for diabetes and obesity drugs from its semaglutide franchise, which continues to grow by leaps and bounds. Novo Nordisk can afford the price cuts prices to several branded and non-branded insulins.

Leads

Leads Pharmaceutical Biopharma Pharma

A leading Democrat reveals how his mental health struggles shape his policy approach

PharmaVoice

AUGUST 17, 2023

Seattle Congressman Adam Smith's journey with anxiety and chronic health has influenced his perspective on healthcare and pharmaceutical policy.

Leads

Leads Healthcare Healthcare Pharmaceutical

Acelyrin’s $300M haul for novel biologic leads a slate of biotech financings

MedCity News

SEPTEMBER 18, 2022

The biggest biotech financing of the past week belongs to a startup developing an immunology drug that could rival blockbuster products sold by big pharmaceutical companies. Cell therapy, cancer, and rare disease also figured into this week’s startup cash hauls.

Leads

Leads Pharmaceutical Biopharma Pharma

Vertex’s CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease

MedCity News

JANUARY 16, 2024

The FDA approved Vertex Pharmaceuticals’ gene therapy Casgevy for treating beta thalassemia, an inherited blood disease that leads to low levels of functioning hemoglobin. Last month, the one-time treatment won its first FDA nod for treating sickle cell disease.

FDA

FDA Pharmaceutical Leads Biopharma

AstraZeneca Joins Radiopharma Deals Spree With $2B Fusion Acquisition

MedCity News

MARCH 19, 2024

AstraZeneca’s Fusion Pharmaceuticals acquisition is the latest in a wave of M&A activity that includes recent deals by Eli Lilly and Bristol Myers Squibb. The lead Fusion program is in mid-stage clinical development for treating advanced prostate cancer.

Pharmaceutical

Pharmaceutical Leads Biopharma Pharma

Otsuka Commits $800M in M&A Deal Bringing a Phase 3-Ready Metabolic Disorder Drug

MedCity News

AUGUST 1, 2024

Otsuka Pharmaceutical is acquiring Jnana Therapeutics, whose lead drug is a potential treatment for the rare metabolic disorder phenylketonuria (PKU). Jnana’s drug could provide an alternative to two FDA-approved PKU medicines from BioMarin Pharmaceutical.

Pharmaceutical

Pharmaceutical Medicine FDA Leads

Sun Pharma Strikes $576M Deal to Get Hair Loss Drug to Rival Lilly, Pfizer Meds

MedCity News

JANUARY 19, 2023

Sun Pharmaceuticals is acquiring Concert Pharmaceuticals, a biotech whose lead program has positive data from two late-stage clinical trials in alopecia areata. The deal gives Sun Pharma a drug candidate that could match up against hair loss drugs from two big pharmaceutical companies.

Pharma

Pharma Pharmaceutical Leads Biopharma

How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come

MedCity News

OCTOBER 20, 2024

Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. During the recent MedCity News INVEST Digital Health conference, a panel discussed these applications and more.

Pharma

Pharma Leads Pharmaceutical Biopharma

Ironwood Places $1B Bet on Biotech That Could Bring Its Next Blockbuster GI Drug

MedCity News

MAY 22, 2023

Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.

Pharmaceutical

Pharmaceutical Leads Biopharma Pharma

EyePoint Pharma Sells U.S. Rights to Eye Med to Become Pure Play Drug Developer

MedCity News

MAY 18, 2023

rights to Yutiq, EyePoint Pharmaceuticals gets $75 million cash to support its drug pipeline. The company’s lead product candidate is in mid-stage development for wet age-related macular degeneration and non-proliferative diabetic retinopathy. By selling U.S.

Pharma

Pharma Pharmaceutical Leads Biopharma

Vertex Pharma Bolsters Immunology Profile With $4.9B Alpine Immune Sciences Acquisition

MedCity News

APRIL 10, 2024

Vertex Pharmaceuticals gains a Phase 3-ready Alpine Immune Sciences drug with potential applications in a wide range of immunological disorders. The lead indication for the Alpine drug, povetacicept, is the chronic kidney disease IgA nephropathy. The post Vertex Pharma Bolsters Immunology Profile With $4.9B

Pharma

Pharma Pharmaceutical Leads Biopharma

Ventyx Drops Drug for Psoriasis as Data Look Uncompetitive in Tight TYK2 Field

MedCity News

NOVEMBER 7, 2023

Ventyx Biosciences is stopping work on its lead drug candidate in plaque psoriasis and psoriatic arthritis. Despite achieving the goals of its Phase 2 test in psoriasis, the results are short of those achieved by big pharmaceutical companies with molecules that address the same target.

Leads

Leads Pharmaceutical Biopharma Pharma

Roche pays $55M for late-stage drug for rare kidney disease with no approved treatment

MedCity News

JULY 11, 2022

An Ionis Pharmaceuticals drug has positive Phase 2 results in immunoglobulin A nephropathy, leading Roche to exercise its option to license the rights to the molecule. The pharmaceutical giant gets a contender in the chase to win the first regulatory approval of a therapy for this rare kidney disease.

Pharmaceutical

Pharmaceutical Leads Biopharma Pharma

Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy

MedCity News

FEBRUARY 17, 2023

The FDA approved Apellis Pharmaceuticals’ Syfovre as a treatment for geographic atrophy, a retinal disorder that is a leading cause of blindness. The drug, administered as an injection into the eye, will launch in March at the price of $2,190 per vial.

FDA

FDA Pharmaceutical Leads Biopharma

Pharmaceutical Advertising: Strategies and Insights for Effective Pharma Marketing

Pharma Marketing Network

JANUARY 11, 2025

Think of pharmaceutical advertising as a delicate balancing actits about connecting with your audience while staying compliant. Crafting Effective Pharmaceutical Advertising Campaigns Pharmaceutical advertising thrives on delivering value. Missteps can lead to hefty fines and reputational damage.

Pharmaceutical

Pharmaceutical Marketing Pharma Healthcare Provider

Rocket Pharma stocks up on cardiac gene therapies with $53M Renovacor acquisition

MedCity News

SEPTEMBER 20, 2022

Rocket Pharmaceuticals is acquiring Renovacor, a gene therapies developer whose lead program addresses a particular genetic mutation that leads to a type of heart failure. The all-stock deal gives Rocket the opportunity to expand its reach in genetically driven cardiac diseases.

Pharma

Pharma Leads Pharmaceutical Biopharma

The top pharmaceutical companies by R&D expenditure

Pharmaceutical Technology

MAY 2, 2024

From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.

Pharmaceutical

Pharmaceutical Leads

AI IN PHARMACEUTICAL MARKETING: Optimizing Automation and Expertise

PM360

JANUARY 24, 2025

AI drives automation and optimization that empower pharmaceutical marketers to rapidly scale commercialization-oriented content and activities. The transformative impact of AI on pharmaceutical marketing is significant, with much to consider regarding its promise and how its reshaping the industry.

Marketing

Marketing Pharmaceutical Pharma Sales pitches

Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Fierce Pharma

MARCH 28, 2024

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Manufacturing

Manufacturing Pharmaceutical Leads

Sanofi hits reset on drug from $2.5B deal after ‘lower than projected’ efficacy in trials

MedCity News

OCTOBER 28, 2022

While the pharmaceutical giant isn’t giving up on the drug, it said it will restart the molecule in a new Phase 1/2 program, a setback that will lead to a €1.6 Sanofi did not see the efficacy it wanted in mid-stage tests of a cytokine therapy from its $2.5 billion acquisition of Synthorx. billion financial writedown.

Leads

Leads Pharmaceutical Biopharma Pharma

Harmony Bio’s Zynerba Buyout Brings Cannabinoid That Doesn’t Spark Euphoria

MedCity News

AUGUST 14, 2023

Zynerba Pharmaceuticals’ lead drug candidate is designed to bring the therapeutic effect of cannabinoids without also causing euphoric effects. The synthetic cannabinoid in a topical gel formulation includes none of the psychoactive compounds from the cannabis plant.

Pharmaceutical

Pharmaceutical Leads Biopharma Pharma

How Networking Leads To Success In Medical Device Sales With Josh Reynolds

Evolve Your Success

JUNE 19, 2024

Learn how a serendipitous summer with a host family in Colorado pivoted his career aspirations towards medical sales, leading to impactful roles with industry giants like Smith & Nephew. Finally, delve into the entrepreneurial spirit that drives Josh’s success.

Networking

Networking Sales Leads Medical

The Road to Building a Leading Pharma Brand: A Product Manager’s Guide

eMediWrite

NOVEMBER 22, 2024

Becoming an outstanding product manager in the pharmaceutical industry and creating a top-tier brand demands a blend of strategic insight, industry expertise, and flawless execution. Deeply Understand Your Market and Audience To create a leading product, you need to understand the therapeutic area thoroughly.

Leads

Leads Pharma Marketing Healthcare Provider

Merck’s $1.3B Imago Buyout Brings Blood Cancer Drug to Rival BMS, Incyte & GSK

MedCity News

NOVEMBER 21, 2022

Merck is acquiring Imago BioSciences, a clinical-stage biotech whose lead drug is in development for myelofibrosis and other blood cancers. The deal gives the pharmaceutical giant a small molecule that could provide an alternative to a class of drugs that introduce dangerous side effects.

Side effects

Side effects Leads Pharmaceutical Biopharma

Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry

Pharmaceutical Technology

SEPTEMBER 23, 2024

Download our free, extensive list of the leading Active Pharmaceutical Ingredients and Intermediates companies and suppliers today.

Pharmaceutical

Pharmaceutical Leads

Leveraging Showpad for Pharmaceutical Sales Teams: A Comprehensive Guide

Infuse Medical

SEPTEMBER 3, 2024

In today’s rapidly evolving digital landscape, pharmaceutical sales teams face unparalleled challenges. Enter Showpad-a leading sales enablement platform designed to revolutionize how pharmaceutical sales teams operate. Learn more about cutting-edge technology that is reshaping the future of pharmaceutical sales.

Pharmaceutical Sales

Pharmaceutical Sales Sales Pharmaceutical Sales presentations

Choosing the Right Pharmaceutical Marketing Company: Strategies for Pharma Success

Pharma Marketing Network

FEBRUARY 17, 2025

Introduction: Choosing the right pharmaceutical marketing company is like picking a strategic partnerit can make or break your brands success. This article will guide you through the strategies for selecting a pharmaceutical marketing company that aligns with your goals, understands your audience, and delivers measurable results.

Marketing

Marketing Pharmaceutical Pharma Prescription

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

APRIL 10, 2025

This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. PFAS are synthetic chemicals, known as forever chemicals found in everyday products across the world, including pharmaceutical products.

Pharmaceutical manufacturing

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products

Pharmaceutical Packaging Companies in Contract Manufacturing for the Pharmaceutical Industry

Pharmaceutical Technology

SEPTEMBER 24, 2024

Discover the leading Pharmaceutical Packaging Companies, Suppliers & Solutions. Download the free Buyer's Guide today for full details.

Pharmaceutical

Pharmaceutical Manufacturing Leads

Sanofi drops out of competitive breast cancer drug race after another trial failure

MedCity News

AUGUST 17, 2022

Sanofi breast cancer drug amcenestrant has failed in a Phase 3 clinical trial, leading the pharmaceutical giant to discontinue all clinical development of the small molecule. The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer.

Competition

Competition Leads Pharmaceutical Patients

Astellas takes a stake in Taysha and gets a chance at next big gene therapy buyout

MedCity News

OCTOBER 25, 2022

Astellas has purchased an equity stake in Taysha Gene Therapies in a $50 million deal that gives it an option to license the company’s two lead gene therapy candidates. The Japanese pharmaceutical giant also gains the option to buy its new partner outright depending on clinical and regulatory developments expected in the coming year.

Leads

Leads Pharmaceutical Biopharma Pharma

Why today’s leading pharma manufacturers are adopting proactive asset management strategies

PharmaVoice

SEPTEMBER 30, 2024

In recent months, high-profile drug shortages have brought pharmaceutical manufacturing operations into the spotlight.

Manufacturing

Manufacturing Pharmaceutical manufacturing Leads Management

Lessons from Training Pharmaceutical Sales Teams: Insights from the Field

Quantified

FEBRUARY 20, 2025

When the pandemic forced teams to shift away from in-person meetings, pharmaceutical sales training leaders had to rethink how they prepared reps for conversations with healthcare professionals. Looking Ahead The way pharmaceutical sales teams are trained has changed, and theres no going back to the old way of doing things.

Pharmaceutical Sales

Pharmaceutical Sales Training Sales Pharmaceutical

Fat-shedding pill’s data lead to a $132M funding round for startup Rivus Pharma

Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study

Trending Sources

Theseus Pharma Lays Off Staff, Explores Options Months After Toxicity Scuttles Lead Drug

After prior trial flop, EyePoint's Duravyu bounces back with promising data in DME

FDA Reconsideration Leads to Approval of Takeda Drug for Rare Esophagus Disorder

In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts

New Hemophilia Data Lead FDA to Delay Decision for BioMarin Gene Therapy

Pfizer moves to settle more than 10,000 Zantac cases in state courts: Bloomberg

‘Challenging Market’ Leads MorphoSys to Cut Preclinical R&D, Turn Focus to Cancer

Amylyx ALS drug’s winding regulatory path leads to long-awaited FDA approval

RA Capital Leads $150M Financing for Septerna and Lead Drug With Oral Edge in Rare Hormone Disease

Novo Nordisk Follows Eli Lilly’s Lead, Lowering Insulin Prices up to 75%

A leading Democrat reveals how his mental health struggles shape his policy approach

Acelyrin’s $300M haul for novel biologic leads a slate of biotech financings

Vertex’s CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease

AstraZeneca Joins Radiopharma Deals Spree With $2B Fusion Acquisition

Otsuka Commits $800M in M&A Deal Bringing a Phase 3-Ready Metabolic Disorder Drug

Sun Pharma Strikes $576M Deal to Get Hair Loss Drug to Rival Lilly, Pfizer Meds

How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come

Ironwood Places $1B Bet on Biotech That Could Bring Its Next Blockbuster GI Drug

EyePoint Pharma Sells U.S. Rights to Eye Med to Become Pure Play Drug Developer

Vertex Pharma Bolsters Immunology Profile With $4.9B Alpine Immune Sciences Acquisition

Ventyx Drops Drug for Psoriasis as Data Look Uncompetitive in Tight TYK2 Field

Roche pays $55M for late-stage drug for rare kidney disease with no approved treatment

Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy

Pharmaceutical Advertising: Strategies and Insights for Effective Pharma Marketing

Rocket Pharma stocks up on cardiac gene therapies with $53M Renovacor acquisition

The top pharmaceutical companies by R&D expenditure

AI IN PHARMACEUTICAL MARKETING: Optimizing Automation and Expertise

Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Sanofi hits reset on drug from $2.5B deal after ‘lower than projected’ efficacy in trials

Harmony Bio’s Zynerba Buyout Brings Cannabinoid That Doesn’t Spark Euphoria

How Networking Leads To Success In Medical Device Sales With Josh Reynolds

The Road to Building a Leading Pharma Brand: A Product Manager’s Guide

Merck’s $1.3B Imago Buyout Brings Blood Cancer Drug to Rival BMS, Incyte & GSK

Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry

Leveraging Showpad for Pharmaceutical Sales Teams: A Comprehensive Guide

Choosing the Right Pharmaceutical Marketing Company: Strategies for Pharma Success

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

Pharmaceutical Packaging Companies in Contract Manufacturing for the Pharmaceutical Industry

Sanofi drops out of competitive breast cancer drug race after another trial failure

Astellas takes a stake in Taysha and gets a chance at next big gene therapy buyout

Why today’s leading pharma manufacturers are adopting proactive asset management strategies

Lessons from Training Pharmaceutical Sales Teams: Insights from the Field

Stay Connected